[EN] HETEROARYLDIHYDROPYRIMIDINE DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFECTIONS<br/>[FR] DÉRIVÉS D'HÉTÉROARYLDIHYDROPYRIMIDINE ET PROCÉDÉS DE TRAITEMENT D'INFECTIONS PAR LE VIRUS DE L'HÉPATITE B
申请人:JANSSEN PHARMACEUTICA NV
公开号:WO2020125730A1
公开(公告)日:2020-06-25
Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
本文提供了用于治疗HBV感染的化合物,包括药物组成和抑制、抑制或预防受试者HBV感染的方法。
NOVEL PYRROLOPYRIMIDINE COMPOUND OR SALT THEREOF, PHARMACEUTICAL COMPOSITION CONTAINING SAME, ESPECIALLY AGENT FOR PREVENTION AND/OR TREATMENT OF TUMORS ETC BASED ON NAE INHIBITORY EFFECT
申请人:TAIHO PHARMACEUTICAL CO., LTD.
公开号:US20170066772A1
公开(公告)日:2017-03-09
An object to be solved by the present invention is to provide a novel pyrrolopyrimidine compound or a salt thereof having an NAE inhibitory action and a cell growth inhibitory effect. The present invention provides a compound or a salt thereof represented by Formula (A), as well as an NAE inhibitor, a pharmaceutical composition, and an antitumor agent comprising the compound or a salt thereof as an active ingredient.
SUBSTITUTED PIPERIDINES THAT INCREASE P53 ACTIVITY AND THE USES THEREOF
申请人:Bogen Stephane L.
公开号:US20120208844A1
公开(公告)日:2012-08-16
The present invention provides a compound of Formula (1) as described herein or a pharmaceutically acceptable salt, solvate or ester thereof. The compounds are useful as inhibitors of the HDM2 protein. Also disclosed are pharmaceutical compositions comprising the above compounds and methods of treating cancer using the same.
SUBSTITUTED PIPERIDINES THAT INCREASE p53 ACTIVITY AND THE USES THEREOF
申请人:Merck Sharp & Dohme Corp.
公开号:US20140336222A1
公开(公告)日:2014-11-13
The present invention provides a compound of Formula 1
as described herein or a pharmaceutically acceptable salt, solvate or ester thereof. The compounds are useful as inhibitors of the HDM2 protein. Also disclosed are pharmaceutical compositions comprising the above compounds and methods of treating cancer using the same.